Identification of genes differentially expressed in osteoclast-like cells

Journal of Interferon and Cytokine Research

Volumn 25, Issue 4, 2005, Pages 227-231

  Nomiyama, Hisayuki ^a   Egami, Kimie ^a   Wada, Naohisa ^b   Tou, Kazuko ^b   Horiuchi, Madoka ^a,c   Matsusaki, Hiromi ^c   Miura, Retsu ^a   Yoshie, Osamu ^d   Kukita, Toshio ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c PREFECTURAL UNIVERSITY OF KUMAMOTO   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DENDRITIC CELL; ENZYME SUBUNIT; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOCLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 17144400724     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.227     Document Type: Article

References (43)

1. ROODMAN, G.D. (1999). Cell biology of the osteoclast. Exp. Hematol. 27, 1229-1241.
2. SUDA, T., TAKAHASHI, N., UDAGAWA, N., JIMI, E., GILLESPIE, M.T., and MARTIN, T.J. (1999). Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357.
3. BOYLE, W.J., SIMONET, W.S., and LACEY, D.L. (2003). Osteoclast differentiation and activation. Nature 423, 337-342.
4. TEITELBAUM, S.L., and ROSS, F.P. (2003). Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649.
5. KONG, Y.Y., YOSHIDA, H., SAROSI, I., TAN, H.L., TIMMS, E., CAPPARELLI, C., MORONY, S., OLIVEIRA-DOS-SANTOS, A.J., VAN, G., ITIE, A., KHOO, W., WAKEHAM, A., DUNSTAN, C.R., LACEY, D.L., MAK, T.W., BOYLE, W.J., and PENNINGER, J.M. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
6. DOUGALL, W.C., GLACCUM, M., CHARRIER, K., ROHRBACH, K., BRASEL, K., DE SMEDT, T., DARO, E., SMITH, J., TOMETSKO, M.E., MALISZEWSKI, C.R., ARMSTRONG, A., SHEN, V., BAIN, S., COSMAN, D., ANDERSON, D., MORRISSEY, P.J., PESCHON, J.J., and SCHUH, J. (1999). RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424.
7. HSU, H., LACEY, D.L., DUNSTAN, C.R., SOLOVYEV, I., COLOMBERO, A., TIMMS, E., TAN, H.L., ELLIOTT, G., KELLEY, M.J., SAROSI, I., WANG, L., XIA, X.Z., ELLIOTT, R., CHIU, L., BLACK, T., SCULLY, S., CAPPARELLI, C., MORONY, S., SHIMAMOTO, G., BASS, M.B., and BOYLE, W.J. (1999). Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96, 3540-3545.
8. CAPPELLEN, D., LUONG-NGUYEN, N.H., BONGIOVANNI, S., GRENET, O., WANKE, C., and SUSA, M. (2002). Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J. Biol. Chem. 277, 21971-21982.
9. ISHIDA, N., HAYASHI, K., HOSHIJIMA, M., OGAWA, T., KOGA, S., MIYATAKE, Y., KUMEGAWA, M., KIMURA, T., and TAKEYA, T. (2002). Large-scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277, 41147-41156.
10. RHO, J., ALTMANN, C.R., SOCCI, N.D., MERKOV, L., KIM, N., SO, H., LEE, O., TAKAMI, M., BRIVANLOU, A.H., and CHOI, Y. (2002). Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol. 21, 541-549.
11. KAWAIDA, R., OHTSUKA, T., OKUTSU, J., TAKAHASHI, T., KADONO, Y., ODA, H., HIKITA, A., NAKAMURA, K., TANAKA, S., and FURUKAWA, H. (2003). Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL. J. Exp. Med. 197, 1029-1035.
12. TAKAYANAGI, H., KIM, S., KOGA, T., NISHINA, H., ISSHIKI, M., YOSHIDA, H., SAIURA, A., ISOBE, M., YOKOCHI, T., INOUE, J., WAGNER, E.F., MAK, T.W., KODAMA, T., and TANIGUCHI, T. (2002). Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901.
13. DAY, C.J., KIM, M.S., STEPHENS, S.R., SIMCOCK, W.E., AITKEN, C.J., NICHOLSON, G.C., and MORRISON, N.A. (2004). Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte-macrophage colony-stimulating factor. J. Cell. Biochem. 91, 303-315.
14. KUBOTA, K., WAKABAYASHI, K., and MATSUOKA, T. (2003). Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography. Proteomics 3, 616-626.
15. WATANABE, T., KUKITA, T., KUKITA, A., WADA, N., TOH, K., NAGATA, K., NOMIYAMA, H., and IIJIMA, T. (2004). Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J. Endocrinol. 180, 193-201.
16. DIATCHENKO, L., LUKYANOV, S., LAU, Y.F., and SIEBERT, P.D. (1999). Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol. 303, 349-380.
17. ZHANG, Y.H., HEULSMANN, A., TONDRAVI, M.M., MUKHERJEE, A., and ABU-AMER, Y. (2001). Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J. Biol. Chem. 276, 563-568.
18. +)-ATPases- nature's most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 3, 94-103.
19. NISHI, T., KAWASAKI-NISHI, S., and FORGAC, M. (2003). Expression and function of 11 the mouse V-ATPase d subunit isoforms. J. Biol. Chem. 278, 46396-46402.
20. UEDA, T., UGAWA, S., and SHIMADA, S. (2003). A novel putative M9.2 isoform of V-ATPase expressed in the nervous system. Neuroreport 14, 25-30.
21. LAITALA-LEINONEN, T., HOWELL, M.L., DEAN, G.E., and VAANANEN, H.K. (1996). Resorption-cycle-dependent polarization of mRNAs for different subunits of V-ATPase in bone-resorbing osteoclasts. Mol. Biol. Cell 7, 129-142.
22. SUN-WADA, G.H., IMAI-SENGA, Y., YAMAMOTO, A., MURATA, Y., HIRATA, T., WADA, Y., and FUTAI, M. (2002). A proton pump ATPase with testis-specific E1-subunit isoform required for acrosome acidification. J. Biol. Chem. 277, 18098-18105.
23. LUDWIG, J., KERSCHER, S., BRANDT, U., PFEIFFER, K., GETLAWI, F., APPS, D. K., and SCHAGGER, H. (1998). Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. 273, 10939-10947.
24. +-ATPase: differential expression of two human subunit B isoforms. Biochem. J. 303, 191-198.
25. +-ATPase C, G and d subunits, and their evaluation in autosomal recessive distal renal tubular acidosis. Gene 297, 169-177.
26. +-ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem. 278, 22023-22030.
27. PETERS, C., BAYER, M.J., BUHLER, S., ANDERSEN, J.S., MANN, M., and MAYER, A. (2001). Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature 409, 581-588.
28. LEAN, J.M., MURPHY, C., FULLER, K., and CHAMBERS, T.J. (2002). CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J. Cell. Biochem. 87, 386-393.
29. ZLOTNIK, A., and YOSHIE, O. (2000). Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.
30. KUKITA, T., NAKAO, J., HAMADA, F., KUKITA, A., INAI, T., KURISU, K., and NOMIYAMA, H. (1992). Recombinant LD78 protein, a member of the small cytokine family, enhances osteoclast differentiation in rat bone marrow culture system. Bone Miner. 19, 215-223.
31. KUKITA, T., NOMIYAMA, H., OHMOTO, Y., KUKITA, A., SHUTO, T., HOTOKEBUCHI, T., SUGIOKA, Y., MIURA, R., and IIJIMA, T. (1997). Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment. Lab. Invest. 76, 399-406.
32. CHOI, S.J., OBA, Y., GAZITT, Y., ALSINA, M., CRUZ, J., ANDERSON, J., and ROODMAN, G.D. (2001). Antisense inhibition of macrophage inflammatory protein I-alpha blocks bone destruction in a model of myeloma bone disease. J. Clin. Invest. 108, 1833-1841.
33. HAN, J.H., CHOI, S.J., KURIHARA, N., KOIDE, M., OBA, Y., and ROODMAN, G.D. (2001). Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97, 3349-3353.
34. ABE, M., HIURA, K., WILDE, J., MORIYAMA, K., HASHIMOTO, T., OZAKI, S., WAKATSUKI, S., KOSAKA, M., KIDO, S., INOUE, D., and MATSUMOTO, T. (2002). Role for macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta in the development of osteolytic lesions in multiple myeloma. Blood 100, 2195-2202.
35. YOUN, B.-S., and KWON, B.S. (2000). MIP-1gamma/MRP-2. In: Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense. J.J. Oppenheim and M. Feldman (eds.) London: Academic Press, pp. 1237-1243.
36. ZHANG, S., YOUN, B.S., GAO, J.L., MURPHY, P.M., and KWON, B.S. (1999). Differential effects of leukotactin-1 and macrophage inflammatory protein-1 alpha on neutrophils mediated by CCR1. J. Immunol. 162, 4938-4942.
37. ZECHNER, R. (1997). The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr. Opin. Lipidol. 8, 77-88.
38. DRAKE, F.H., DODDS, R.A., JAMES, I.E., CONNOR, J.R., DEBOUCK, C., RICHARDSON, S., LEE-RYKACZEWSKI, E., COLEMAN, L., RIEMAN, D., BARTHLOW, R., HASTINGS, G., and GOWEN, M. (1996). Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271, 12511-12516.
39. DACI, E., EVERTS, V., TORREKENS, S., VAN HERCK, E., TIGCHELAAR-GUTTERR, W., BOUILLON, R., and CARMELIET, G. (2003). Increased bone formation in mice lacking plasminogen activators. J. Bone Miner. Res. 18, 1167-1176.
40. ARAI, N., OHYA, K., and OGURA, H. (1993). Osteopontin mRNA expression during bone resorption: an in situ hybridization study of induced ectopic bone in the rat. Bone Miner. 22, 129-145.
41. YAP, K.L., AMES, J.B., SWINDELLS, M.B., and IKURA, M. (1999). Diversity of conformational states and changes within the EF-hand protein superfamily. Proteins 37, 499-507.
42. HARTGERS, F.C., VISSERS, J.L., LOOMAN, M.W., VAN ZOELEN, C., HUFFINE, C., FIGDOR, C.G., and ADEMA, G.J. (2000). DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur. J. Immunol. 30, 3585-3590.
43. KUKITA, T., WADA, N., KUKITA, A., KAKIMOTO, T., SANDRA, F., TOH, K., NAGATA, K., IIJIMA, T., HORIUCHI, M., MATSUSAKI, H., HIESHIMA, K., YOSHIE, O., and NOMIYAMA, H. (2004). RANKL-induced DC-STAMP is a key transmembrane molecule in osteoclastogenesis. J. Exp. Med. 200, 941-946.